Company: INVUP
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022223
Chunk: 112

Company: Investview, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 112
---
 sales,
respectively. The $4.1 million (37%) decrease in membership revenue was due to the global macroeconomic downturn as individuals re-evaluated
their spending priorities, lifestyle habits, and engagement preferences, causing a slowdown in direct sales and home-based businesses.
This decrease was offset by the $356 thousand or 63% increase in mining revenue, a direct result of an increase in the price of Bitcoin,
partially offset by an increase in Bitcoin Network Difficulty and a $1.0 million increase in health and wellness product sales that arose
from our October 2024 acquisition of the business and assets of Renu Laboratories, Inc.

Operating
Costs and Expenses

    Three Months Ended September 30,  
    Increase 

    2025  
    2024  
    (Decrease) 

    (unaudited)  
    (unaudited)  

    Cost of sales and service 
    $2,153,524  
    $1,257,569  
    $895,955 
  
    Commissions 
     4,008,062  
     6,270,310  
     (2,262,248)
  
    Selling and marketing 
     356,556  
     16,751  
     339,805 
  
    Salary and related 
     1,773,323  
     1,471,649  
     301,674 
  
    Professional fees 
     536,090  
     416,410  
     119,680 
  
    Impairment expense 
     -  
     977,418  
     (977,418)
  
    Gain on disposal of assets 
     (21,414) 
     -  
     (21,414)
  
    General and administrative 
     1,284,273  
     2,031,269  
     (746,996)
  
    Total operating costs and expenses 
    $10,090,414  
    $12,441,376  
    $(2,350,962)

33

Operating
costs decreased $2,350,962 or (19%), from $12,441,376 for the three months ended September 30, 2024, to $10,090,414 for the three
months ended September 30, 2025. The decrease can be